The deal between Carlos Correa and the New York Mets is still out of balance as neither party has put forward any definitive terms as to whether the deal is going in the best possible direction.
Carlos Correa and the San Francisco Giants reached agreement on a 13-year, $350 million deal on December 14. I am concerned about his medical report.
“For Correa, not signing now means risking never seeing anything close to that amount again,” AnthonyDiComo recently tweeted.
Instead, Correa president Scott Boras said goodbye to the Giants, spoke with Mets owner Steve Cohen, and agreed to a 12-year, $315 million contract with the team.
This happened in the early hours of December 21, and Correa flew to New York the next day to undergo a physical examination. The deal has been kept out of the crowd by the Mets, who, like the Giants, were concerned about Correa’s medical report.
What’s the story behind the Mets organization’s backroom about signing Carlos Correa?
After reaching an agreement with the team, the athlete will typically travel to the new team’s facility for a physical and contract signing. In most cases, this procedure is formal in nature. Very rarely.
“Both the Mets and Team CJ Correa have far more to lose by somehow not completing this transaction,” TheKingSource recently tweeted.
Carlos Correa’s right ankle, which he underwent surgery while playing in the minor leagues in 2014, is clearly worrying the Mets. It hasn’t kept him out of action over the past eight seasons, despite the fact that it hurt.
Correa’s contract runs for over a year. If so, you’re probably fine. The Mets will have to rely on his ability to remain reasonably healthy during this 12-year commitment. If there is reason to think, that’s a big deal.
The most logical course of action would be for both parties to negotiate new language in the player’s contract that would protect the Mets from Carlos Correa’s potential career-ending ankle injury. How to do it is hard. That’s part of the reason why this process takes so long.